Combination Therapy for Solid Tumors: Taking a Classic CAR on New Adventures.
Cancer Cell
; 38(5): 621-623, 2020 11 09.
Article
em En
| MEDLINE
| ID: mdl-33064993
CD19-specific CAR-T cell therapies are the gold standard of adoptive cellular immunotherapy for hematopoietic malignancies. In Science Translational Medicine, Park et al. develop an oncolytic vaccinia virus that introduces truncated CD19 expression in solid tumors, which are then eradicated by CD19-specific CAR-T cells in immunodeficient and immunocompetent mouse models.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vírus Oncolíticos
/
Neoplasias
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article